IP Library Assignment 050052/0509
Patent Assignment
Reel/Frame 050052/0509

Assignment of Assignor's Interest

Recorded: 2019-08-14 Pages: 6
Assignor
ZENITH CAPITAL CORP.
Executed: 2016-11-21
Assignee
ZENITH EPIGENETICS LTD.
300,4820 RICHARD ROAD SW, CALGARY, AB, T3E6L1, CANADA
Covered Property (1)
Substituted Bicyclic Compounds as Bromodomain Inhibitors
Application: 16/251,536 →
Publication: US 2019/0216782
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
General Conveyance and Assumption Agreement Aug 14, 2019
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENTICS CORP.
Reel/Frame 050053/0343 →
Assignment of Assignor's Interest Aug 14, 2019
From: LIU, SHUANG; DUFFY, BRYAN CORDELL; WANG, RUIFANG; JIANG, MAY XIAOWU
To: RVX THERAPEUTICS INC.
Reel/Frame 050053/0352 →
Assignment of Assignor's Interest Aug 14, 2019
From: LIU, SHUANG; QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; WANG, RUIFANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 050053/0460 →
Change of Name Aug 14, 2019
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 050053/0705 →